Skip to main content
. 2019 Aug 16;60(9):816–823. doi: 10.3349/ymj.2019.60.9.816

Table 1. Baseline Characteristics according to the Presence of Specific Cardiomyopathy.

No CM (n=1119) DCM (n=10) HCM (n=17) LVNC (n=40) p value
Age (yr) 56±15 56±5 60±13 51±16*‡ 0.097
Male 793 (71) 8 (80) 13 (77) 35 (88)* 0.135
Body mass index (kg/m2) 23.9±3.6 23.7±3.5 24.7±2.2 23.4±3.2 0.666
Hypertension 462 (41) 3 (30) 10 (59) 17 (43) 0.444
Diabetes mellitus 209 (19) 3 (30) 9 (52)* 4 (10) 0.001
Dyslipidemia 231 (21) 1 (10) 3 (18) 10 (25) 0.742
CAD 182 (16) 0 (0) 2 (12) 5 (13) 0.464
CKD 97 (9) 3 (30)* 2 (12) 4 (10) 0.124
Heart failure 178 (16) 6 (60)* 8 (47) 8 (20)†‡ <0.001
 Preserved EF 129 (12) 0 (0) 8 (47)*† 6 (15) <0.001
 Reduced EF 49 (4) 6 (60)* 0 (0) 2 (5) <0.001

CM, cardiomyopathy; DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; LVNC, left ventricular non-compaction; CAD, coronary artery disease; CKD, chronic kidney disease; EF, ejection fraction.

Values are presented as mean±standard deviation or n (%) unless otherwise indicated.

*p<0.05 compared to the group with no CM; p<0.05 compared to the DCM group; p<0.05 compared to the HCM group.